Display options
Cite
Chien LW, Lin MH, Chung HY, et al. Transcutaneous electrical stimulation of acupoints changes body composition and heart rate variability in postmenopausal women with obesity. Evid Based Complement Alternat Med. 2011;2011:862121doi: 10.1093/ecam/nep145.
Chien, L. W., Lin, M. H., Chung, H. Y., & Liu, C. F. (2011). Transcutaneous electrical stimulation of acupoints changes body composition and heart rate variability in postmenopausal women with obesity. Evidence-based complementary and alternative medicine : eCAM, 2011862121. https://doi.org/10.1093/ecam/nep145
Chien, Li-Wei, et al. "Transcutaneous electrical stimulation of acupoints changes body composition and heart rate variability in postmenopausal women with obesity." Evidence-based complementary and alternative medicine : eCAM vol. 2011 (2011): 862121. doi: https://doi.org/10.1093/ecam/nep145
Chien LW, Lin MH, Chung HY, Liu CF. Transcutaneous electrical stimulation of acupoints changes body composition and heart rate variability in postmenopausal women with obesity. Evid Based Complement Alternat Med. 2011;2011:862121. doi: 10.1093/ecam/nep145. Epub 2011 Feb 20. PMID: 19773390; PMCID: PMC3137740.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2011;2011:862121. doi: 10.1093/ecam/nep145. Epub 2011 Feb 20.

Transcutaneous electrical stimulation of acupoints changes body composition and heart rate variability in postmenopausal women with obesity.

Evidence-based complementary and alternative medicine : eCAM

Li-Wei Chien, Miao-Hsiang Lin, Hsueh-Yu Chung, Chi-Feng Liu

Affiliations

  1. Department of Obstetrics and Gynecology, Taipei Medical University and Hospital, Tàipei, Taiwan.

PMID: 19773390 PMCID: PMC3137740 DOI: 10.1093/ecam/nep145

Abstract

This study aimed to evaluate the effect of transcutaneous electric acupoint stimulations (TEAS) on body composition and heart rate variability (HRV) in postmenopausal women with obesity. In this prospective study, 49 postmenopausal women were recruited in Taiwan. Body composition was used as a screening test for obesity (percentage body fat > 30%, waist circumference > 80 cm). The experimental group (n = 24) received TEAS treatment 30 min twice per week for 12 weeks at the Zusanli (ST 36) and Sanyinjiao (SP 6) acupoints. The control group (n = 25) did not receive any intervention. The study of HRV was analyzed by time (standard deviation of the normal-to-normal (NN) intervals (SDNN) and square root of the mean squared differences of successive NN intervals (RMSSD) indices) and frequency domain methods. Power spectral components were obtained at low (LF) and high (HF) frequencies. Body composition and HRV values were measured at the 4th, 8th, and 12th weeks. A total of 40 subjects completed this study. Waist circumference and percentage body fat in the experimental group (n = 20) were significantly less than those of the control group (n = 20) at the 8th and 12th weeks (all P < .05). Additionally, at the same time points, percentage lean body mass in the experimental group was significantly greater than that in the control group (P < .05). SDNN values increased significantly at the 4th and 8th weeks when compared with the control group (all P < .05). At 12 weeks, SDNN value was not significantly different from that of the control group (P = .105). TEAS treatment improves body composition, and has a transient effect on the HRV in postmenopausal women with obesity.

References

  1. Int J Obes Relat Metab Disord. 2003 Apr;27(4):419-27 - PubMed
  2. Evid Based Complement Alternat Med. 2011;2011:503698 - PubMed
  3. Am J Chin Med. 2005;33(1):157-64 - PubMed
  4. Eur J Appl Physiol. 2006 Jul;97(5):542-7 - PubMed
  5. J Womens Health (Larchmt). 2005 Jun;14(5):434-40 - PubMed
  6. Prev Med. 2003 Sep;37(3):233-41 - PubMed
  7. Eur J Appl Physiol. 2003 Jan;88(4-5):404-10 - PubMed
  8. Am J Cardiol. 1999 Apr 15;83(8):1242-7 - PubMed
  9. Evid Based Complement Alternat Med. 2004 Jun 1;1(1):41-47 - PubMed
  10. Auton Neurosci. 2007 May 30;133(2):158-69 - PubMed
  11. N Engl J Med. 1988 Apr 28;318(17):1077-83 - PubMed
  12. Int J Obes (Lond). 2009 Feb;33(2):183-96 - PubMed
  13. J Clin Endocrinol Metab. 2002 Sep;87(9):4166-70 - PubMed
  14. Circulation. 1998 May 26;97(20):2037-42 - PubMed
  15. Arch Phys Med Rehabil. 2002 Jul;83(7):1024-7 - PubMed
  16. Circulation. 1996 Mar 1;93(5):1043-65 - PubMed
  17. Complement Ther Clin Pract. 2006 May;12(2):97-100 - PubMed
  18. Ann Intern Med. 1995 Nov 1;123(9):673-5 - PubMed
  19. Auton Neurosci. 2008 Feb 29;138(1-2):91-8 - PubMed
  20. Obes Rev. 2001 Feb;2(1):3-14 - PubMed
  21. Gynecol Endocrinol. 2005 Apr;20(4):227-35 - PubMed
  22. J Tradit Chin Med. 1999 Mar;19(1):48-51 - PubMed
  23. Neurochem Res. 2008 Oct;33(10):2023-7 - PubMed
  24. J Clin Endocrinol Metab. 2007 Mar;92(3):895-901 - PubMed
  25. Evid Based Complement Alternat Med. 2011;2011:969231 - PubMed
  26. Brain Res Bull. 1995;36(2):141-8 - PubMed
  27. J Clin Endocrinol Metab. 2003 Jun;88(6):2404-11 - PubMed
  28. Obes Res. 2001 Oct;9(10):637-43 - PubMed
  29. Exp Biol Med (Maywood). 2003 Nov;228(10):1201-7 - PubMed
  30. Arch Intern Med. 2003 Feb 24;163(4):427-36 - PubMed
  31. Obes Res. 1996 Jan;4(1):55-63 - PubMed

Publication Types